Arabic Arabic English English French French German German
dark

Rubius Therapeutics Appoints Jim Jogerst as Chief Business Officer

Rubius Therapeutics, Inc. today announced the appointment of Jim Jogerst as chief business officer. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

How Pharma Startups Can Remain Competitive in Today’s Market

Next Post

Sonnet Announces Successful Completion of the Discovery Phase for Its Next Preclinical Pipeline Candidate (SON-1410)

Related Posts
Total
0
Share